The genetics of selective serotonin reuptake inhibitors

Pharmacology and Therapeutics

Volumn 136, Issue 3, 2012, Pages 375-400

  Kroeze, Yvet ^a   Zhou, Huiqing ^b   Homberg, Judith R ^a  

^a RADBOUD UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epigenetics; Hypothalamic system; Inflammatory system; Neuroplasticity; Serotonin; SSRI

Indexed keywords

4 AMINOBUTYRIC ACID; CATECHOL METHYLTRANSFERASE; CITALOPRAM; DESIPRAMINE; DOPAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; GLUTAMIC ACID; GLYCINE; GTP CYCLOHYDROLASE I FEEDBACK REGULATOR PROTEIN; HYPOTHALAMUS HORMONE; IPSAPIRONE; MESSENGER RNA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROTROPHIC FACTOR; NORADRENALIN; PAROXETINE; PROOPIOMELANOCORTIN; REGULATOR PROTEIN; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

AGE; ARTICLE; DEPRESSION; DOPAMINE BRAIN LEVEL; DRUG EFFICACY; DRUG TARGETING; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INDEL MUTATION; LYMPHOBLAST; NERVE CELL PLASTICITY; NONHUMAN; NORADRENALIN BRAIN LEVEL; PHARMACOGENETICS; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 84867857598     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.08.015     Document Type: Review

References (308)

1. S.H. Abbasi, F. Hosseini, A. Modabbernia, M. Ashrafi, and S. Akhondzadeh Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study J Affect Disord 2012 10.1016/j.jad.2012.03.033 (prepubished on 18 Apr, 2012 as)
2. N. Abumaria, R. Rygula, C. Hiemke, E. Fuchs, U. Havemann-Reinecke, and E. Ruther Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat Eur Neuropsychopharmacol 17 2007 417 429
3. S. Alboni, C. Benatti, G. Capone, D. Corsini, F. Caggia, and F. Tascedda Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats Eur J Pharmacol 643 2010 180 187
4. A.E. Allain, L. Segu, P. Meyrand, and P. Branchereau Serotonin controls the maturation of the GABA phenotype in the ventral spinal cord via 5-HT1b receptors Ann NY Acad Sci 1198 2010 208 219
5. M.S. Ansorge, M. Zhou, A. Lira, R. Hen, and J.A. Gingrich Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice Science 306 2004 879 881
6. J.P. Anthony, T.J. Sexton, and J.F. Neumaier Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation J Neurosci Res 61 2000 82 87
7. B. Arias, R. Catalan, C. Gasto, B. Gutierrez, and L. Fananas 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study J Clin Psychopharmacol 23 2003 563 567
8. B. Arias, R. Catalan, C. Gasto, B. Gutierrez, and L. Fananas Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram J Psychopharmacol 19 2005 166 172
9. B. Arias, A. Serretti, L. Mandelli, C. Gasto, R. Catalan, and D.D. Ronchi Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors Pharmacogenet Genomics 19 2009 121 128
10. F. Artigas, L. Romero, C. de Montigny, and P. Blier Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists Trends Neurosci 19 1996 378 383
11. M. Bannai, N. Kawai, K. Nagao, S. Nakano, D. Matsuzawa, and E. Shimizu Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats Psychiatry Clin Neurosci 65 2011 142 149
12. A. Barbon, C. Orlandi, L. La Via, L. Caracciolo, D. Tardito, and L. Musazzi Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus Neuropsychobiology 63 2011 160 168
13. A. Baudry, S. Mouillet-Richard, B. Schneider, J.M. Launay, and O. Kellermann miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants Science 329 2010 1537 1541
14. N. Bel, and F. Artigas Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei Synapse 15 1993 243 245
15. F. Benedetti, C. Colombo, A. Pirovano, E. Marino, and E. Smeraldi The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting Psychopharmacology (Berl) 203 2009 155 160
16. F. Benedetti, S. Dallaspezia, C. Colombo, C. Lorenzi, A. Pirovano, and E. Smeraldi Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine Eur Psychiatry 25 2010 476 478
17. S. Benloucif, and M.P. Galloway Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis Eur J Pharmacol 200 7-23-1991 1 8
18. S. Benmansour, M. Cecchi, D.A. Morilak, G.A. Gerhardt, M.A. Javors, and G.G. Gould Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level J Neurosci 19 1999 10494 10501
19. M.A. Benson, S.E. Newey, E. Martin-Rendon, R. Hawkes, and D.J. Blake Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain J Biol Chem 276 2001 24232 24241
20. H.O. Besedovsky, A. del Rey, I. Klusman, H. Furukawa, A.G. Monge, and A. Kabiersch Cytokines as modulators of the hypothalamus-pituitary-adrenal axis J Steroid Biochem Mol Biol 40 1991 613 618
21. A.Y. Bespalov, M.M. van Gaalen, and G. Gross Antidepressant treatment in anxiety disorders Curr Top Behav Neurosci 2 2010 361 390
22. A.M. Bielecka, M. Paul-Samojedny, and E. Obuchowicz Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture Naunyn Schmiedebergs Arch Pharmacol 382 2010 409 417
23. E.B. Binder, M.J. Owens, W. Liu, T.C. Deveau, A.J. Rush, and M.H. Trivedi Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response Arch Gen Psychiatry 67 2010 369 379
24. U. Boer, C. Noll, I. Cierny, D. Krause, C. Hiemke, and W. Knepel A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: reversal of chronic psychosocial stress-induced increase in CRE/CREB-directed gene transcription in transgenic reporter gene mice Eur J Pharmacol 633 2010 33 38
25. A. Bortolozzi, A. Castane, J. Semakova, N. Santana, G. Alvarado, and R. Cortes Selective siRNA-mediated suppression of 5-HT(1A) autoreceptors evokes strong anti-depressant-like effects Mol Psychiatry 17 2011 612 623
26. S. Bouali, A. Evrard, M. Chastanet, K.P. Lesch, M. Hamon, and J. Adrien Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter Eur J Neurosci 18 2003 2203 2212
27. S. Boularand, M.C. Darmon, P. Ravassard, and J. Mallet Characterization of the human tryptophan hydroxylase gene promoter. Transcriptional regulation by cAMP requires a new motif distinct from the cAMP-responsive element J Biol Chem 270 1995 3757 3764
28. L.S. Brady, P.W. Gold, M. Herkenham, A.B. Lynn, and H.J. Whitfield Jr. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications Brain Res 572 1992 117 125
29. W.A. Carlezon Jr., R.S. Duman, and E.J. Nestler The many faces of CREB Trends Neurosci 28 2005 436 445
30. J.L. Carrasco, and C. Sandner Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview Int J Clin Pract 59 2005 1428 1434
31. I. Ceglia, S. Acconcia, C. Fracasso, M. Colovic, S. Caccia, and R.W. Invernizzi Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors Br J Pharmacol 142 2004 469 478
32. C.D. Chambers, S. Hernandez-Diaz, L.J. Van Marter, M.M. Werler, C. Louik, and K.L. Jones Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn N Engl J Med 354 2006 579 587
33. C.D. Chambers, K.A. Johnson, L.M. Dick, R.J. Felix, and K.L. Jones Birth outcomes in pregnant women taking fluoxetine N Engl J Med 335 1996 1010 1015
34. F. Chen, T.M. Madsen, G. Wegener, and J.R. Nyengaard Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression Hippocampus 20 2010 1376 1384
35. P.S. Chen, T.L. Yeh, I.H. Lee, C.B. Lin, H.C. Tsai, and K.C. Chen Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers-a SPECT study Neuroimage 56 2011 1526 1530
36. X. Chen, L.L. Yuan, C. Zhao, S.G. Birnbaum, A. Frick, and W.E. Jung Deletion of Kv4.2 gene eliminates dendritic A-type K+ current and enhances induction of long-term potentiation in hippocampal CA1 pyramidal neurons J Neurosci 26 2006 12143 12151
37. M.F. Chesselet, and T.D. Reisine Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei J Neurosci 3 1983 232 236
38. M.H. Chi, H.H. Chang, S.Y. Lee, I.H. Lee, P.W. Gean, and Y.K. Yang Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder J Affect Disord 126 2010 430 435
39. M.J. Choi, R.H. Kang, B.J. Ham, H.Y. Jeong, and M.S. Lee Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram Neuropsychobiology 52 2005 155 162
40. M.J. Choi, R.H. Kang, S.W. Lim, K.S. Oh, and M.S. Lee Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder Brain Res 1118 2006 176 182
41. I. Churruca, M.P. Portillo, L. Casis, A. Gutierrez, M.T. Macarulla, and E. Echevarria Effects of fluoxetine administration on hypothalamic melanocortin system in obese Zucker rats Neuropeptides 42 2008 293 299
42. H.W. Clement, D. Gemsa, and W. Wesemann Serotonin-norepinephrine interactions: a voltammetric study on the effect of serotonin receptor stimulation followed in the N. raphe dorsalis and the Locus coeruleus of the rat J Neural Transm Gen Sect 88 1992 11 23
43. M. Conti, and S.L. Jin The molecular biology of cyclic nucleotide phosphodiesterases Prog Nucleic Acid Res Mol Biol 63 1999 1 38
44. H.E. Covington III, I. Maze, Q.C. LaPlant, V.F. Vialou, Y.N. Ohnishi, and O. Berton Antidepressant actions of histone deacetylase inhibitors J Neurosci 29 2009 11451 11460
45. J.F. Cryan, O.F. O'Leary, S.H. Jin, J.C. Friedland, M. Ouyang, and B.R. Hirsch Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors Proc Natl Acad Sci U S A 101 2004 8186 8191
46. S. Cummings, R. Elde, J. Ells, and A. Lindall Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study J Neurosci 3 1983 1355 1368
47. J.A. Cutler, A.J. Rush, F.J. McMahon, and G. Laje Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder J Psychopharmacol 26 2012 360 367
48. G. Dagestad, S.D. Kuipers, E. Messaoudi, and C.R. Bramham Chronic fluoxetine induces region-specific changes in translation factor eIF4E and eEF2 activity in the rat brain Eur J Neurosci 23 2006 2814 2818
49. Y. Dang, W.E. Dale, and O.R. Brown Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway Free Radic Biol Med 28 2000 615 624
50. R. Dantzer, J.C. O'Connor, M.A. Lawson, and K.W. Kelley Inflammation-associated depression: from serotonin to kynurenine Psychoneuroendocrinology 36 2011 426 436
51. L.C. Daws, J.L. Munn, M.F. Valdez, T. Frosto-Burke, and J.G. Hensler Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice J Neurochem 101 2007 641 651
52. P. De Deurwaerdère, N. Bonhomme, G. Lucas, M.M. Le, and U. Spampinato Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites J Neurochem 66 1996 210 215
53. G. De Foubert, S.L. Carney, C.S. Robinson, E.J. Destexhe, R. Tomlinson, and C.A. Hicks Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment Neuroscience 128 2004 597 604
54. P. De Sarno, G.N. Bijur, A.A. Zmijewska, X. Li, and R.S. Jope In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors Neurobiol Aging 27 2006 413 422
55. T. Deltheil, B.P. Guiard, J. Cerdan, D.J. David, K.F. Tanaka, and C. Reperant Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice Neuropharmacology 55 2008 1006 1014
56. A. Di Lieto, D. Leo, F. Volpicelli, U. di Porzio, and L. Colucci-D'Amato Fluoxetine modifies the expression of serotonergic markers in a differentiation-dependent fashion in the mesencephalic neural cell line A1 mes c-myc Brain Res 1143 2007 1 10
57. L. Donnici, E. Tiraboschi, D. Tardito, L. Musazzi, G. Racagni, and M. Popoli Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells BMC Neurosci 9 2008 61
58. A. Drago, C. Crisafulli, A. Sidoti, and A. Serretti The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes Prog Neurobiol 94 2011 418 460
59. C. D'Sa, A.J. Eisch, G.B. Bolger, and R.S. Duman Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration Eur J Neurosci 22 2005 1463 1475
60. J. Duan, A.R. Sanders, J.E. Molen, L. Martinolich, B.J. Mowry, and D.F. Levinson Polymorphisms in the 5′-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression Mol Psychiatry 8 2003 901 910
61. R.S. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol Psychiatry 59 2006 1116 1127
62. N.N. Dygalo, G.T. Shishkina, T.S. Kalinina, A.M. Yudina, and E.S. Ovchinnikova Effect of repeated treatment with fluoxetine on tryptophan hydroxylase-2 gene expression in the rat brainstem Pharmacol Biochem Behav 85 2006 220 227
63. M. Dziedzicka-Wasylewska, R. Rogoz, V. Klimek, and J. Maj Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain J Neural Transm 104 1997 515 524
64. M.F. Egan, M. Kojima, J.H. Callicott, T.E. Goldberg, B.S. Kolachana, and A. Bertolino The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function Cell 112 2003 257 269
65. M. El Mansari, and P. Blier Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition J Psychiatry Neurosci 30 2005 268 274
66. M.T. Englander, S.C. Dulawa, P. Bhansali, and C. Schmauss How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing J Neurosci 25 2005 648 651
67. V. Fabre, C. Beaufour, A. Evrard, A. Rioux, N. Hanoun, and K.P. Lesch Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter Eur J Neurosci 12 2000 2299 2310
68. C. Fields, L. Drye, V. Vaidya, and C. Lyketsos Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial Am J Geriatr Psychiatry 20 2012 505 513
69. M.F. Flament, H. Bissada, and W. Spettigue Evidence-based pharmacotherapy of eating disorders Int J Neuropsychopharmacol 15 2012 189 207
70. J.C. Florez, and J.S. Takahashi Regulation of tryptophan hydroxylase by cyclic AMP, calcium, norepinephrine, and light in cultured chick pineal cells J Neurochem 67 1996 242 250
71. M. Foguet, J.A. Hartikka, K. Schmuck, and H. Lubbert Long-term regulation of serotonergic activity in the rat brain via activation of protein kinase A EMBO J 12 1993 903 910
72. J.A. Garcia-Sevilla, M. varo-Bartolome, R. ez-Alarcia, A. Ramos-Miguel, D. Puigdemont, and V. Perez Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients Eur Neuropsychopharmacol 20 2010 721 730
73. A.M. Gardier Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor Behav Pharmacol 20 2009 18 32
74. Y.T. Gau, Y.J. Liou, Y.W. Yu, T.J. Chen, M.W. Lin, and S.J. Tsai Evidence for association between genetic variants of p75 neurotrophin receptor (p75NTR) gene and antidepressant treatment response in Chinese major depressive disorder Am J Med Genet B Neuropsychiatr Genet 147B 2008 594 599
75. M. Gil, X. Zhen, and E. Friedman Prenatal cocaine exposure alters glycogen synthase kinase-3beta (GSK3beta) pathway in select rabbit brain areas Neurosci Lett 349 2003 143 146
76. A. Gladkevich, H.F. Kauffman, and J. Korf Lymphocytes as a neural probe: potential for studying psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 28 2004 559 576
77. G. Gobbi, D.L. Murphy, K. Lesch, and P. Blier Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study J Pharmacol Exp Ther 296 2001 987 995
78. C.B. Green, J.C. Besharse, and M. Zatz Tryptophan hydroxylase mRNA levels are regulated by the circadian clock, temperature, and cAMP in chick pineal cells Brain Res 738 1996 1 7
79. F. Gressier, E. Bouaziz, C. Verstuyft, P. Hardy, L. Becquemont, and E. Corruble 5-HTTLPR modulates antidepressant efficacy in depressed women Psychiatr Genet 19 2009 195 200
80. G. Grignaschi, F. Sironi, and R. Samanin Stimulation of 5-HT2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of corticotropin releasing factor Brain Res 708 1996 173 176
81. E. Gudayol-Ferre, I. Herrera-Guzman, B. Camarena, C. Cortes-Penagos, J.E. Herrera-Abarca, and P. Martinez-Medina The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder J Affect Disord 127 2010 343 351
82. G. Guidotti, F. Calabrese, F. Auletta, J. Olivier, G. Racagni, and J. Homberg Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment Neuropsychopharmacology 37 2012 746 758
83. G.J. Guillemin, S.J. Kerr, L.A. Pemberton, D.G. Smith, G.A. Smythe, and P.J. Armati IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment J Interferon Cytokine Res 21 2001 1097 1101
84. C. Gundlah, S. Hjorth, and S.B. Auerbach Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment Neuropharmacology 36 1997 475 482
85. J.Y. Guo, C.Y. Li, Y.P. Ruan, M. Sun, X.L. Qi, and B.S. Zhao Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain Eur J Pharmacol 612 2009 54 60
86. M. Gutierrez-Mariscal, P. de Gortari, C. Lopez-Rubalcava, A. Martinez, and P. Joseph-Bravo Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety Psychoneuroendocrinology 33 2008 198 213
87. A.L. Halberstadt, V.D. Lehmann-Masten, M.A. Geyer, and S.B. Powell Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice Psychopharmacology (Berl) 215 2011 81 92
88. B.J. Ham, B.C. Lee, J.W. Paik, R.H. Kang, M.J. Choi, and I.G. Choi Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population Prog Neuropsychopharmacol Biol Psychiatry 31 2007 104 107
89. T.A. Hammad Review and evaluation of clinical data. Relationship between psychiatric drugs and pediatric suicidal behavior 2008 U.S. Food and Drug Administration (FDA) [Available: http://www.fda.gov/OHRMS/DOCKETS/ac/04/ briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf (accessed February 20, 2012)]
90. N.D. Hanson, C.B. Nemeroff, and M.J. Owens Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus J Pharmacol Exp Ther 337 2011 180 186
91. S.E. Hardt, and J. Sadoshima Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development Circ Res 90 2002 1055 1063
92. T. Hattori, N. Takei, Y. Mizuno, K. Kato, and S. Kohsaka Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain Neurosci Res 21 1995 191 198
93. A. Heils, R. Mossner, and K.P. Lesch The human serotonin transporter gene polymorphism - basic research and clinical implications J Neural Transm 104 1997 1005 1014
94. K. Held, H. Kunzel, M. Ising, D.A. Schmid, A. Zobel, and H. Murck Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression J Psychiatr Res 38 2004 129 136
95. W. Heydendael, and L. Jacobson Widespread hypothalamic-pituitary- adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice Eur J Neurosci 31 2010 892 902
96. K. Hinkelmann, L. Dragoi, J. Gompf, C. Muhtz, C. Demiralay, and A. Yassouridis Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype Psychiatry Res 177 2010 354 357
97. A. Holmes, Q. Lit, D.L. Murphy, E. Gold, and J.N. Crawley Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background Genes Brain Behav 2 2003 365 380
98. F. Holsboer, and M. Ising Central CRH system in depression and anxiety - evidence from clinical studies with CRH1 receptor antagonists Eur J Pharmacol 583 2008 350 357
99. A.J. Holtmaat, P.A. Dijkhuizen, A.B. Oestreicher, H.J. Romijn, N.M. Van der Lugt, and A. Berns Directed expression of the growth-associated protein B-50/GAP-43 to olfactory neurons in transgenic mice results in changes in axon morphology and extraglomerular fiber growth J Neurosci 15 1995 7953 7965
100. J.R. Homberg, S.F. De Boer, H.S. Raaso, J.D. Olivier, M. Verheul, and E. Ronken Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats Psychopharmacology (Berl) 200 2008 367 380
101. J.R. Homberg, J.D. Olivier, T. Blom, T. Arentsen, B.C. van, and P. Schipper Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat PLoS One 6 2011 e16646
102. J.R. Homberg, J.D. Olivier, B.M. Smits, J.D. Mul, J. Mudde, and M. Verheul Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system Neuroscience 146 2007 1662 1676
103. J.R. Homberg, D. Schubert, and P. Gaspar New perspectives on the neurodevelopmental effects of SSRIs Trends Pharmacol Sci 31 2010 60 65
104. C.J. Hong, T.J. Chen, Y.W. Yu, and S.J. Tsai Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder Pharmacogenomics J 6 2006 27 33
105. S. Horstmann, S. Lucae, A. Menke, J.M. Hennings, M. Ising, and D. Roeske Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment Neuropsychopharmacology 35 2010 727 740
106. D. Hranilovic, J. Stefulj, S. Schwab, M. Borrmann-Hassenbach, M. Albus, and B. Jernej Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression Biol Psychiatry 55 2004 1090 1094
107. X. Hu, G. Oroszi, J. Chun, T.L. Smith, D. Goldman, and M.A. Schuckit An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk Alcohol Clin Exp Res 29 2005 8 16
108. P. Huezo-Diaz, R. Uher, R. Smith, M. Rietschel, N. Henigsberg, and A. Marusic Moderation of antidepressant response by the serotonin transporter gene Br J Psychiatry 195 2009 30 38
109. R. Iceta, J.E. Mesonero, and A.I. Alcalde Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells Life Sci 80 2007 1517 1524
110. A. Illi, O. Poutanen, E. Setala-Soikkeli, O. Kampman, M. Viikki, and H. Huhtala Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD? Eur Arch Psychiatry Clin Neurosci 261 2011 95 102
111. A. Illi, E. Setala-Soikkeli, O. Kampman, M. Viikki, T. Nuolivirta, and O. Poutanen Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder Psychiatry Res 176 2010 85 87
112. A. Illi, E. Setala-Soikkeli, M. Viikki, O. Poutanen, H. Huhtala, and N. Mononen 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression Neuroreport 20 2009 1125 1128
113. R. Invernizzi, M. Bramante, and R. Samanin Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram Brain Res 696 1995 62 66
114. K. Ito, K. Yoshida, K. Sato, H. Takahashi, M. Kamata, and H. Higuchi A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine Psychiatry Res 111 2002 235 239
115. R. Janz, T.C. Sudhof, R.E. Hammer, V. Unni, S.A. Siegelbaum, and V.Y. Bolshakov Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I Neuron 24 1999 687 700
116. J.B. Jensen, D.S. Jessop, M.S. Harbuz, A. Mork, C. Sanchez, and J.D. Mikkelsen Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats J Neuroendocrinol 11 1999 465 471
117. J.B. Jensen, J.D. Mikkelsen, and A. Mork Increased adenylyl cyclase type 1 mRNA, but not adenylyl cyclase type 2 in the rat hippocampus following antidepressant treatment Eur Neuropsychopharmacol 10 2000 105 111
118. Y. Ji, J. Biernacka, K. Snyder, M. Drews, L.L. Pelleymounter, and C. Colby Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response Pharmacogenomics J 12 2012 78 85
119. Y. Ji, S. Hebbring, H. Zhu, G.D. Jenkins, J. Biernacka, and K. Snyder Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics Clin Pharmacol Ther 89 2011 97 104
120. S.P. Ji, Y. Zhang, C.J. Van, W. Jiang, M. Liao, and L. Li Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse Nat Med 12 2006 324 329
121. D.A. Johnson, C.D. Ingram, E.J. Grant, M. Craighead, and S.E. Gartside Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter Neuropsychopharmacology 34 2009 399 409
122. P.R. Joyce, R.T. Mulder, S.E. Luty, J.M. McKenzie, A.L. Miller, and G.R. Rogers Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline Int J Neuropsychopharmacol 6 2003 339 346
123. A.V. Kalueff, M.A. Fox, P.S. Gallagher, and D.L. Murphy Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice Genes Brain Behav 6 2007 389 400
124. N. Kaneko, K. Kudo, T. Mabuchi, K. Takemoto, K. Fujimaki, and H. Wati Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus Neuropsychopharmacology 31 2006 2619 2626
125. F. Karege, G. Vaudan, M. Schwald, N. Perroud, and H.R. La Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs Brain Res Mol Brain Res 136 2005 29 37
126. M. Kato, T. Fukuda, M. Wakeno, K. Fukuda, G. Okugawa, and Y. Ikenaga Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients Neuropsychobiology 53 2006 186 195
127. M. Kato, and A. Serretti Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder Mol Psychiatry 15 2010 473 500
128. M. Kato, M. Wakeno, G. Okugawa, T. Fukuda, Y. Takekita, and Y. Hosoi Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1041 1044
129. M. Kato, R. Zanardi, D. Rossini, D. De Ronchi, G. Okugawa, and T. Kinoshita 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients Psychiatry Res 167 2009 97 105
130. Y. Kim, S.H. Kim, Y.S. Kim, Y.H. Lee, K. Ha, and S.Y. Shin Imipramine activates glial cell line-derived neurotrophic factor via early growth response gene 1 in astrocytes Prog Neuropsychopharmacol Biol Psychiatry 35 2011 1026 1032
131. H. Kim, S.W. Lim, S. Kim, J.W. Kim, Y.H. Chang, and B.J. Carroll Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression JAMA 296 2006 1609 1618
132. S.W. Kim, S.Y. Park, and O. Hwang Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline Mol Pharmacol 61 2002 778 785
133. J. Kirchheiner, K. Nickchen, J. Sasse, M. Bauer, I. Roots, and J. Brockmoller A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment Pharmacogenomics J 7 2007 48 55
134. T. Kishi, Y. Fukuo, R. Yoshimura, T. Okochi, T. Kitajima, and H. Naitoh Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population Hum Psychopharmacol 25 2010 481 486
135. T. Kishi, T. Kitajima, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, and K. Kawashima CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients Neuromolecular Med 11 2009 53 57
136. T. Kishi, R. Yoshimura, T. Kitajima, T. Okochi, T. Okumura, and T. Tsunoka HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort Neuromolecular Med 12 2010 237 242
137. T. Kitagami, K. Yamada, H. Miura, R. Hashimoto, T. Nabeshima, and T. Ohta Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier Brain Res 978 2003 104 114
138. M.E. Kozisek, D. Middlemas, and D.B. Bylund The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment Neuropharmacology 54 2008 251 257
139. J.B. Kraft, E.J. Peters, S.L. Slager, G.D. Jenkins, M.S. Reinalda, and P.J. McGrath Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample Biol Psychiatry 61 2007 734 742
140. G. Kreiner, A. Bielawski, A. Zelek-Molik, M. Kowalska, and I. Nalepa Chronic treatment with citalopram does not affect the expression of alpha1-adrenergic receptor (alpha1-AR) subtypes Pol J Pharmacol 56 2004 831 836
141. D.S. Kreiss, and I. Lucki Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo J Pharmacol Exp Ther 274 1995 866 876
142. C. Kriegebaum, L. Gutknecht, A. Schmitt, K.P. Lesch, and A. Reif Serotonin now: Part 1. Neurobiology and developmental genetics Fortschr Neurol Psychiatr 78 2010 319 331
143. M.G. Kris, P.J. Hesketh, J. Herrstedt, C. Rittenberg, L.H. Einhorn, and S. Grunberg Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy Support Care Cancer 13 2005 85 96
144. S. Kusakawa, K. Nakamura, Y. Miyamoto, A. Sanbe, T. Torii, and J. Yamauchi Fluoxetine promotes gliogenesis during neural differentiation in mouse embryonic stem cells J Neurosci Res 88 2010 3479 3487
145. S. Kusakawa, J. Yamauchi, Y. Miyamoto, A. Sanbe, and A. Tanoue Estimation of embryotoxic effect of fluoxetine using embryonic stem cell differentiation system Life Sci 83 2008 871 877
146. C.H. Lammers, J. Diaz, J.C. Schwartz, and P. Sokoloff Dopamine D3 receptor gene expression in the shell of nucleus accumbens is increased by chronic antidepressant treatment Mol Psychiatry 5 2000 229
147. M.H. Larsen, A. Hay-Schmidt, L.C. Ronn, and J.D. Mikkelsen Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants Eur J Pharmacol 578 2008 114 122
148. T. Lau, S. Horschitz, S. Berger, D. Bartsch, and P. Schloss
149. E. Le Poul, C. Boni, N. Hanoun, A.M. Laporte, N. Laaris, and J. Chauveau Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine Neuropharmacology 39 2000 110 122
150. S.H. Lee, T.K. Choi, E. Lee, J.H. Seok, S.H. Lee, and H.S. Lee Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine Neuropsychobiology 62 2010 198 206
151. R. Lee, P. Kermani, K.K. Teng, and B.L. Hempstead Regulation of cell survival by secreted proneurotrophins Science 294 2001 1945 1948
152. S. Lemonde, L. Du, D. Bakish, P. Hrdina, and P.R. Albert Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response Int J Neuropsychopharmacol 7 2004 501 506
153. S. Lemonde, G. Turecki, D. Bakish, L. Du, P.D. Hrdina, and C.D. Bown Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide J Neurosci 23 2003 8788 8799
154. E.J. Lenze, A.M. Goate, P. Nowotny, D. Dixon, P. Shi, and R.R. Bies Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults J Clin Psychopharmacol 30 2010 672 677
155. G.M. Levin, T.M. Bowles, M.J. Ehret, T. Langaee, J.Y. Tan, and J.A. Johnson Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness Mol Diagn Ther 11 2007 155 160
156. B. Li, S. Zhang, H. Zhang, L. Hertz, and L. Peng Fluoxetine affects GluK2 editing, glutamate-evoked Ca(2+) influx and extracellular signal-regulated kinase phosphorylation in mouse astrocytes J Psychiatry Neurosci 36 2011 322 338
157. X. Li, W. Zhu, M.S. Roh, A.B. Friedman, K. Rosborough, and R.S. Jope In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain Neuropsychopharmacology 29 2004 1426 1431
158. T. Lifschytz, E. Gur, B. Lerer, and M.E. Newman Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences J Neurosci Methods 140 2004 133 139
159. E. Lin, P.S. Chen, H.H. Chang, P.W. Gean, H.C. Tsai, and Y.K. Yang Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder Prog Neuropsychopharmacol Biol Psychiatry 33 2009 1167 1172
160. A. Lin, C. Song, G. Kenis, E. Bosmans, J.R. De, and S. Scharpe The in vitro immunosuppressive effects of moclobemide in healthy volunteers J Affect Disord 58 2000 69 74
161. A. Lira, M. Zhou, N. Castanon, M.S. Ansorge, J.A. Gordon, and J.H. Francis Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice Biol Psychiatry 54 2003 960 971
162. Z. Liu, F. Zhu, G. Wang, Z. Xiao, J. Tang, and W. Liu Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders Neurosci Lett 414 2007 155 158
163. A. Lockridge, J. Su, and L.L. Yuan Abnormal 5-HT modulation of stress behaviors in the Kv4.2 knockout mouse Neuroscience 170 2010 1086 1097
164. S. Lucae, D. Salyakina, N. Barden, M. Harvey, B. Gagne, and M. Labbe P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder Hum Mol Genet 15 2006 2438 2445
165. C.C. Mannoury la, C. Boni, N. Hanoun, K.P. Lesch, M. Hamon, and L. Lanfumey Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity J Neurosci 21 2001 2178 2185
166. C.A. Marcinkiewcz, M.M. Prado, S.K. Isaac, A. Marshall, D. Rylkova, and A.W. Bruijnzeel Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats Neuropsychopharmacology 34 2009 1743 1752
167. M. Marcoli, C. Cervetto, P. Paluzzi, S. Guarnieri, S. Alloisio, and S. Thellung P2X7 pre-synaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release J Neurochem 105 2008 2330 2342
168. E. Maron, A. Tammiste, K. Kallassalu, T. Eller, V. Vasar, and D.J. Nutt Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression Eur Neuropsychopharmacol 19 2009 451 456
169. A. Matuzany-Ruban, M. Golan, N. Miroshnik, G. Schreiber, and S. Avissar Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants Int J Neuropsychopharmacol 13 2010 83 91
170. J.F. Maya Vetencourt, E. Tiraboschi, M. Spolidoro, E. Castren, and L. Maffei Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats Eur J Neurosci 33 2011 49 57
171. P.C. McHugh, P.R. Joyce, X. Deng, and M.A. Kennedy A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants Pharmacogenomics J 11 2011 207 213
172. F.J. McMahon, S. Buervenich, D. Charney, R. Lipsky, A.J. Rush, and A.F. Wilson Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment Am J Hum Genet 78 2006 804 814
173. P.A. Melas, M. Rogdaki, A. Lennartsson, K. Bjork, H. Qi, and A. Witasp Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression Int J Neuropsychopharmacol 2011 1 11
174. L. Menard, S.S. Ferguson, L.S. Barak, L. Bertrand, R.T. Premont, and A.M. Colapietro Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration Biochemistry 35 1996 4155 4160
175. J.A. Mennigen, E.A. Harris, J.P. Chang, T.W. Moon, and V.L. Trudeau Fluoxetine affects weight gain and expression of feeding peptides in the female goldfish brain Regul Pept 155 2009 99 104
176. J.A. Mennigen, C.J. Martyniuk, K. Crump, H. Xiong, E. Zhao, and J. Popesku Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus) Physiol Genomics 35 2008 273 282
177. D. Michelson, E. Galliven, L. Hill, M. Demitrack, G. Chrousos, and P. Gold Chronic imipramine is associated with diminished hypothalamic-pituitary- adrenal axis responsivity in healthy humans J Clin Endocrinol Metab 82 1997 2601 2606
178. D. Michelson, B. Misiewicz-Poltorak, R.B. Raybourne, P.W. Gold, and E.M. Sternberg Imipramine reduces the local inflammatory response to carrageenin Agents Actions 42 1994 25 28
179. W. Min, T. Li, X. Ma, Z. Li, T. Yu, and D. Gao Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response Psychopharmacology (Berl) 205 2009 409 417
180. X. Miro, S. Perez-Torres, F. Artigas, P. Puigdomenech, J.M. Palacios, and G. Mengod Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study Neuropharmacology 43 2002 1148 1157
181. C. Monaca, B. Boutrel, R. Hen, M. Hamon, and J. Adrien 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice Neuropsychopharmacology 28 2003 850 856
182. M.L. Monje, H. Toda, and T.D. Palmer Inflammatory blockade restores adult hippocampal neurogenesis Science 302 2003 1760 1765
183. A. Morag, M. Pasmanik-Chor, V. Oron-Karni, M. Rehavi, J.C. Stingl, and D. Gurwitz Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker Pharmacogenomics 12 2011 171 184
184. J.A. Moron, I. Zakharova, J.V. Ferrer, G.A. Merrill, B. Hope, and E.M. Lafer Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity J Neurosci 23 2003 8480 8488
185. S.S. Moy, J.J. Nadler, N.B. Young, R.J. Nonneman, A.W. Grossman, and D.L. Murphy Social approach in genetically engineered mouse lines relevant to autism Genes Brain Behav 8 2009 129 142
186. D. Natarajan, S.F. de Boer, and J.M. Koolhaas Lack of differential serotonin biosynthesis capacity in genetically selected low and high aggressive mice Physiol Behav 98 2009 411 415
187. E.J. Nestler, R.Z. Terwilliger, and R.S. Duman Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex J Neurochem 53 1989 1644 1647
188. Y.G. Ni, and R. Miledi Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac) Proc Natl Acad Sci U S A 94 1997 2036 2040
189. M. Nibuya, E.J. Nestler, and R.S. Duman Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J Neurosci 16 1996 2365 2372
190. N.M. Nicolaou, M. Garcia-Munoz, G.W. Arbuthnott, and D. Eccleston Interactions between serotonergic and dopaminergic systems in rat brain demonstrated by small unilateral lesions of the raphe nuclei Eur J Pharmacol 57 1979 295 305
191. K. Nonogaki, K. Nozue, Y. Takahashi, N. Yamashita, S. Hiraoka, and H. Kumano Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors Int J Neuropsychopharmacol 10 2007 675 681
192. K. Nonogaki, Y. Ohba, M. Wakameda, and T. Tamari Fluvoxamine exerts anorexic effect in 5-HT2C receptor mutant mice with heterozygous mutation of beta-endorphin gene Int J Neuropsychopharmacol 12 2009 547 552
193. C.W. Noorlander, F.F. Ververs, P.G. Nikkels, C.J. van Echteld, G.H. Visser, and M.P. Smidt Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities PLoS One 3 2008 e2782
194. C. Normann, D. Schmitz, A. Furmaier, C. Doing, and M. Bach Long-term plasticity of visually evoked potentials in humans is altered in major depression Biol Psychiatry 62 2007 373 380
195. R.A. North Molecular physiology of P2X receptors Physiol Rev 82 2002 1013 1067
196. M.M. Nowacka, and E. Obuchowicz Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action Neuropeptides 46 2012 1 10
197. J.E. Oh, B. Zupan, S. Gross, and M. Toth Paradoxical anxiogenic response of juvenile mice to fluoxetine Neuropsychopharmacology 34 2009 2197 2207
198. M. Olfson, S.C. Marcus, and D. Shaffer Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study Arch Gen Psychiatry 63 2006 865 872
199. J.D. Olivier, T. Blom, T. Arentsen, and J.R. Homberg The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review Prog Neuropsychopharmacol Biol Psychiatry 35 2011 1400 1408
200. J.D. Olivier, A. Valles, H.F. van, A. frasiab-Middelman, J.J. Roelofs, and M. Jonkers Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring Psychopharmacology (Berl) 217 2011 419 432
201. J.D. Olivier, M.G. Van Der Hart, R.P. Van Swelm, P.J. Dederen, J.R. Homberg, and T. Cremers A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders Neuroscience 152 2008 573 584
202. T.W. Pace, F. Hu, and A.H. Miller Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression Brain Behav Immun 21 2007 9 19
203. S. Paddock, G. Laje, D. Charney, A.J. Rush, A.F. Wilson, and A.J. Sorant Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort Am J Psychiatry 164 2007 1181 1188
204. D.T. Page, O.J. Kuti, C. Prestia, and M. Sur Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior Proc Natl Acad Sci U S A 106 2009 1989 1994
205. E. Paizanis, T. Renoir, V. Lelievre, F. Saurini, M. Melfort, and C. Gabriel Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice Int J Neuropsychopharmacol 13 2010 759 774
206. E.P. Palvimaki, B.L. Roth, H. Majasuo, A. Laakso, M. Kuoppamaki, and E. Syvalahti Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor Psychopharmacology (Berl) 126 1996 234 240
207. D.K. Pandey, R. Mahesh, A.A. Kumar, V.S. Rao, M. Arjun, and R. Rajkumar A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants Pharmacol Biochem Behav 94 2010 363 373
208. S. Papiol, B. Arias, C. Gasto, B. Gutierrez, R. Catalan, and L. Fananas Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment J Affect Disord 104 2007 83 90
209. R.H. Perlis, G. Laje, J.W. Smoller, M. Fava, A.J. Rush, and F.J. McMahon Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients Neuropsychopharmacology 34 2009 1819 1828
210. G. Perna, E. Favaron, D. Di Bella, R. Bussi, and L. Bellodi Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene Neuropsychopharmacology 30 2005 2230 2235
211. N. Perroud, K.J. Aitchison, R. Uher, R. Smith, P. Huezo-Diaz, and A. Marusic Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project Neuropsychopharmacology 34 2009 2517 2528
212. E.J. Peters, S.L. Slager, G.D. Jenkins, M.S. Reinalda, H.A. Garriock, and S.I. Shyn Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response Pharmacogenet Genomics 19 2009 1 10
213. E.J. Peters, S.L. Slager, J.B. Kraft, G.D. Jenkins, M.S. Reinalda, and P.J. McGrath Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample PLoS One 3 2008 e1872
214. E.J. Peters, S.L. Slager, P.J. McGrath, J.A. Knowles, and S.P. Hamilton Investigation of serotonin-related genes in antidepressant response Mol Psychiatry 9 2004 879 889
215. F. Pilar-Cuellar, R. Vidal, and A. Pazos Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, beta-catenin and antidepressant-like effects Br J Pharmacol 165 2012 1046 1057
216. E. Poleszak, P. Wlaz, B. Szewczyk, A. Wlaz, R. Kasperek, and A. Wrobel A complex interaction between glycine/NMDA receptors and serotonergic/ noradrenergic antidepressants in the forced swim test in mice J Neural Transm 118 2011 1535 1546
217. B.G. Pollock, R.E. Ferrell, B.H. Mulsant, S. Mazumdar, M. Miller, and R.A. Sweet Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression Neuropsychopharmacology 23 2000 587 590
218. D. Popa, C. Lena, C. Alexandre, and J. Adrien Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior J Neurosci 28 2008 3546 3554
219. J. Popp, S. Leucht, S. Heres, and W. Steimer Serotonin transporter polymorphisms and side effects in antidepressant therapy - a pilot study Pharmacogenomics 7 2006 159 166
220. S. Porcelli, C. Fabbri, and A. Serretti Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy Eur Neuropsychopharmacol 22 2012 239 258
221. M.J. Portella, J. de Diego-Adelino, J. Ballesteros, D. Puigdemont, S. Oller, and B. Santos Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression J Clin Psychiatry 72 2011 962 969
222. E. Prosperini, M. Rizzi, F. Fumagalli, G. Tarizzo, R. Samanin, and C. Bendotti Acute and chronic treatments with citalopram lower somatostatin levels in rat brain striatum through different mechanisms J Neurochem 69 1997 206 213
223. J.L. Rausch, C.F. Gillespie, Y. Fei, H.M. Hobby, T. Stoming, and V. Ganapathy Antidepressant effects on kinase gene expression patterns in rat brain Neurosci Lett 334 2002 91 94
224. J.L. Rausch, M.E. Johnson, Y.J. Fei, J.Q. Li, N. Shendarkar, and H.M. Hobby Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome Biol Psychiatry 51 2002 723 732
225. E. Real, M. Gratacos, V. Soria, G. Escaramis, P. Alonso, and C. Segalas A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder Biol Psychiatry 66 2009 674 680
226. U. Rescher, and V. Gerke S100A10/p11: family, friends and functions Pflugers Arch 455 2008 575 582
227. J.M. Reul, M.S. Labeur, D.E. Grigoriadis, E.B. De Souza, and F. Holsboer Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide Neuroendocrinology 60 1994 509 519
228. A. Routtenberg, I. Cantallops, S. Zaffuto, P. Serrano, and U. Namgung Enhanced learning after genetic overexpression of a brain growth protein Proc Natl Acad Sci U S A 97 2000 7657 7662
229. H.G. Ruhe, N.S. Mason, and A.H. Schene Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies Mol Psychiatry 12 2007 331 359
230. A.A. Russo-Neustadt, H. Alejandre, C. Garcia, A.S. Ivy, and M.J. Chen Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise Neuropsychopharmacology 29 2004 2189 2199
231. J.B. Sakash, G.I. Byrne, A. Lichtman, and P. Libby Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-associated cells: implications for persistent Chlamydophila pneumoniae infection Infect Immun 70 2002 3959 3961
232. A.J. Sales, C. Biojone, M.S. Terceti, F.S. Guimaraes, M.V. Gomes, and S.R. Joca Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors Br J Pharmacol 164 2011 1711 1721
233. J.J. Schildkraut The catecholamine hypothesis of affective disorders: a review of supporting evidence Am J Psychiatry 122 1965 509 522
234. S.L. Sell, R.M. Craft, P.K. Seitz, S.J. Stutz, K.A. Cunningham, and M.L. Thomas Estradiol-sertraline synergy in ovariectomized rats Psychoneuroendocrinology 33 2008 1051 1060
235. A. Serretti, F. Benedetti, R. Zanardi, and E. Smeraldi The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments Prog Neuropsychopharmacol Biol Psychiatry 29 2005 1074 1084
236. A. Serretti, R. Calati, L. Mandelli, and D. De Ronchi Serotonin transporter gene variants and behavior: a comprehensive review Curr Drug Targets 7 2006 1659 1669
237. A. Serretti, R. Calati, I. Massat, S. Linotte, S. Kasper, and Y. Lecrubier Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients Int Clin Psychopharmacol 24 2009 250 256
238. A. Serretti, M. Kato, D. De Ronchi, and T. Kinoshita Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients Mol Psychiatry 12 2007 247 257
239. A. Serretti, C. Lorenzi, C. Cusin, R. Zanardi, E. Lattuada, and D. Rossini SSRIs antidepressant activity is influenced by G beta 3 variants Eur Neuropsychopharmacol 13 2003 117 122
240. A. Serretti, R. Zanardi, C. Cusin, D. Rossini, R. Lilli, and C. Lorenzi No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors Psychiatry Res 104 2001 195 203
241. A. Serretti, R. Zanardi, C. Cusin, D. Rossini, C. Lorenzi, and E. Smeraldi Tryptophan hydroxylase gene associated with paroxetine antidepressant activity Eur Neuropsychopharmacol 11 2001 375 380
242. J. Shelton, P. Bonaventure, X. Li, S. Yun, T. Lovenberg, and C. Dugovic 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor Neuropharmacology 56 2009 448 454
243. Q. Shen, R. Lal, B.A. Luellen, J.C. Earnheart, A.M. Andrews, and B. Luscher gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression Biol Psychiatry 68 2010 512 520
244. K. Shioe, T. Ichimiya, T. Suhara, A. Takano, Y. Sudo, and F. Yasuno No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET Synapse 48 2003 184 188
245. Y. Shirayama, A.C. Chen, S. Nakagawa, D.S. Russell, and R.S. Duman Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression J Neurosci 22 2002 3251 3261
246. G.T. Shishkina, T.S. Kalinina, and N.N. Dygalo Up-regulation of tryptophan hydroxylase-2 mRNA in the rat brain by chronic fluoxetine treatment correlates with its antidepressant effect Neuroscience 150 2007 404 412
247. H. Silva, P. Iturra, A. Solari, J. Villarroel, S. Jerez, and M. Jimenez Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder Psychiatr Genet 20 2010 25 30
248. E. Smeraldi, R. Zanardi, F. Benedetti, B.D. Di, J. Perez, and M. Catalano Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine Mol Psychiatry 3 1998 508 511
249. K. Smits, L. Smits, F. Peeters, J. Schouten, R. Janssen, and H. Smeets Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors Int Clin Psychopharmacol 22 2007 137 143
250. K.M. Smits, L.J. Smits, F.P. Peeters, J.S. Schouten, R.G. Janssen, and H.J. Smeets The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients Psychiatr Genet 18 2008 184 190
251. K.M. Smits, L.J. Smits, J.S. Schouten, F.F. Stelma, P. Nelemans, and M.H. Prins Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review Mol Psychiatry 9 2004 433 441
252. D.J. Stein, J. Ipser, and N. McAnda Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines CNS Spectr 14 2009 25 31
253. L.Q. Stewart, J.A. Roper, W.S. Young III, A.M. O'Carroll, and S.J. Lolait Pituitary-adrenal response to acute and repeated mild restraint, forced swim and change in environment stress in arginine vasopressin receptor 1b knockout mice J Neuroendocrinol 20 2008 597 605
254. M.N. Subhash, B.N. Srinivas, K.Y. Vinod, and S. Jagadeesh Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain J Neural Transm 107 2000 377 387
255. M.C. Swan, A.R. Najlerahim, and J.P. Bennett Expression of serotonin transporter mRNA in rat brain: presence in neuronal and non-neuronal cells and effect of paroxetine J Chem Neuroanat 13 1997 71 76
256. A. Szegedi, D. Rujescu, A. Tadic, M.J. Muller, R. Kohnen, and H.H. Stassen The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression Pharmacogenomics J 5 2005 49 53
257. A. Tadic, D. Rujescu, M.J. Muller, R. Kohnen, H.H. Stassen, and A. Szegedi Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression Neuropsychiatr Dis Treat 4 2008 269 276
258. M. Takahashi, R. Terwilliger, C. Lane, P.S. Mezes, M. Conti, and R.S. Duman Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms J Neurosci 19 1999 610 618
259. H. Takahashi, K. Yoshida, K. Ito, K. Sato, M. Kamata, and H. Higuchi No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment Eur Neuropsychopharmacol 12 2002 477 481
260. N. Takei, J. Kondo, K. Nagaike, K. Ohsawa, K. Kato, and S. Kohsaka Neuronal survival factor from bovine brain is identical to neuron-specific enolase J Neurochem 57 1991 1178 1184
261. J.N. Talbot, E.M. Jutkiewicz, S.M. Graves, C.F. Clemans, M.R. Nicol, and R.M. Mortensen RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects Proc Natl Acad Sci U S A 107 2010 11086 11091
262. M. Taler, I. Gil-Ad, L. Lomnitski, I. Korov, E. Baharav, and M. Bar Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression Eur Neuropsychopharmacol 17 2007 774 780
263. M. Tanaka, D. Kobayashi, Y. Murakami, N. Ozaki, T. Suzuki, and N. Iwata Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea Int J Neuropsychopharmacol 11 2008 261 267
264. M. Tatsumi, K. Groshan, R.D. Blakely, and E. Richelson Pharmacological profile of antidepressants and related compounds at human monoamine transporters Eur J Pharmacol 340 1997 249 258
265. S. Tavoulari, L.R. Forrest, and G. Rudnick Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes J Neurosci 29 2009 9635 9643
266. H.K. Teng, K.K. Teng, R. Lee, S. Wright, S. Tevar, and R.D. Almeida ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin J Neurosci 25 2005 5455 5463
267. M. Thakur, I. Grossman, D.C. McCrory, L.A. Orlando, D.C. Steffens, and K.E. Cline Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors Genet Med 9 2007 826 835
268. K.L. Thomas, V.L. Ellingrod, J.R. Bishop, and M.J. Keiser A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach Psychopharmacol Bull 43 2010 11 22
269. J. Thome, N. Sakai, K. Shin, C. Steffen, Y.J. Zhang, and S. Impey cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment J Neurosci 20 2000 4030 4036
270. S.J. Tsai, C.Y. Cheng, Y.W. Yu, T.J. Chen, and C.J. Hong Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response Am J Med Genet B Neuropsychiatr Genet 123B 2003 19 22
271. S.J. Tsai, Y.T. Gau, C.J. Hong, Y.J. Liou, Y.W. Yu, and T.J. Chen Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients J Affect Disord 113 2009 183 187
272. S.J. Tsai, C.J. Hong, Y.J. Liou, T.J. Chen, M.L. Chen, and S.J. Hou Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder Psychiatry Res 169 2009 113 117
273. S.J. Tsai, C.J. Hong, Y.J. Liou, Y.W. Yu, and T.J. Chen Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response Pharmacogenet Genomics 18 2008 869 875
274. S.J. Tsai, C.J. Hong, Y.J. Liou, Y.W. Yu, T.J. Chen, and S.J. Hou Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response Prog Neuropsychopharmacol Biol Psychiatry 33 2009 637 641
275. S.J. Tsai, Y.J. Liou, C.J. Hong, Y.W. Yu, and T.J. Chen Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder Pharmacogenomics J 8 2008 384 390
276. N.M. Tsankova, O. Berton, W. Renthal, A. Kumar, R.L. Neve, and E.J. Nestler Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action Nat Neurosci 9 2006 519 525
277. C.W. Tsao, Y.S. Lin, C.C. Chen, C.H. Bai, and S.R. Wu Cytokines and serotonin transporter in patients with major depression Prog Neuropsychopharmacol Biol Psychiatry 30 2006 899 905
278. M.V. Tzvetkov, J. Brockmoller, I. Roots, and J. Kirchheiner Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment Pharmacogenet Genomics 18 2008 495 506
279. R. Uher, N. Perroud, M.Y. Ng, J. Hauser, N. Henigsberg, and W. Maier Genome-wide pharmacogenetics of antidepressant response in the GENDEP project Am J Psychiatry 167 2010 555 564
280. P. Vanhoutte, and H. Bading Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation Curr Opin Neurobiol 13 2003 366 371
281. M. Verhagen, M.A. van der, P.A. van Deurzen, J.G. Janzing, A. rias-Vasquez, and J.K. Buitelaar Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity Mol Psychiatry 15 2010 260 271
282. M. Viikki, K. Huuhka, E. Leinonen, A. Illi, E. Setala-Soikkeli, and M. Huuhka Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD Neurosci Lett 501 2011 20 24
283. M. Viikki, O. Kampman, S. Anttila, A. Illi, E. Setala-Soikkeli, and M. Huuhka P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT Neurosci Lett 493 2011 127 130
284. S.M. Villafuerte, K. Vallabhaneni, E. Sliwerska, F.J. McMahon, E.A. Young, and M. Burmeister SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A Psychiatr Genet 19 2009 281 291
285. H.C. Wang, T.L. Yeh, H.H. Chang, P.W. Gean, M.H. Chi, and Y.K. Yang TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients Psychopharmacology (Berl) 213 2011 773 779
286. J.L. Warner-Schmidt, M. Flajolet, A. Maller, E.Y. Chen, H. Qi, and P. Svenningsson Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation J Neurosci 29 2009 1937 1946
287. A. Weizman, and R. Weizman Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse Pharmacogenomics 1 2000 335 341
288. M.B. Wilkinson, G. Xiao, A. Kumar, Q. LaPlant, W. Renthal, and D. Sikder Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models J Neurosci 29 2009 7820 7832
289. K. Williams, D.M. Wheeler, N. Silove, and P. Hazell Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD) Cochrane Database Syst Rev 2010 CD004677
290. P. Willner, S. Lappas, S. Cheeta, and R. Muscat Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole Psychopharmacology (Berl) 115 1994 454 462
291. D.T. Wong, F.P. Bymaster, and E.A. Engleman Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication Life Sci 57 1995 411 441
292. W.M. Wong, S. Hasemann, M. Schwarz, P. Zill, G. Koller, and M. Soyka Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results Pharmacopsychiatry 41 2008 72 78
293. H.Q. Wu, A. Rassoulpour, and R. Schwarcz Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm 114 2007 33 41
294. T.L. Xu, J. Nabekura, and N. Akaike Protein kinase C-mediated enhancement of glycine response in rat sacral dorsal commissural neurones by serotonin J Physiol 496 Pt 2 1996 491 501
295. J.L. Yau, C. Hibberd, J. Noble, and J.R. Seckl The effect of chronic fluoxetine treatment on brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats Brain Res Mol Brain Res 106 2002 117 123
296. O.O. Yevtushenko, M.M. Oros, and G.P. Reynolds Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism J Affect Disord 123 2010 308 311
297. K. Yoshida, H. Higuchi, M. Kamata, H. Takahashi, K. Inoue, and T. Suzuki The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine J Psychopharmacol 21 2007 650 656
298. K. Yoshida, K. Ito, K. Sato, H. Takahashi, M. Kamata, and H. Higuchi Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients Prog Neuropsychopharmacol Biol Psychiatry 26 2002 383 386
299. Y.W. Yu, T.J. Chen, C.J. Hong, H.M. Chen, and S.J. Tsai Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response Neuropsychopharmacology 28 2003 1182 1185
300. Y.W. Yu, S.J. Tsai, T.J. Chen, C.H. Lin, and C.J. Hong Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders Mol Psychiatry 7 2002 1115 1119
301. Y.W. Yu, S.J. Tsai, Y.J. Liou, C.J. Hong, and T.J. Chen Association study
302. R. Zanardi, F. Benedetti, D. Di Bella, M. Catalano, and E. Smeraldi Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene J Clin Psychopharmacol 20 2000 105 107
303. R. Zanardi, A. Serretti, D. Rossini, L. Franchini, C. Cusin, and E. Lattuada Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression Biol Psychiatry 50 2001 323 330
304. C.B. Zhu, R.D. Blakely, and W.A. Hewlett The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters Neuropsychopharmacology 31 2006 2121 2131
305. A.W. Zobel, T. Nickel, H.E. Kunzel, N. Ackl, A. Sonntag, and M. Ising Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated J Psychiatr Res 34 2000 171 181
306. Y.F. Zou, Y. Wang, P. Liu, X.L. Feng, B.Y. Wang, and T.H. Zang Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients Neuropsychobiology 61 2010 71 78
307. Y.F. Zou, D.Q. Ye, X.L. Feng, H. Su, F.M. Pan, and F.F. Liao Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder Eur Neuropsychopharmacol 20 2010 535 544
308. M. Zusso, P. Debetto, D. Guidolin, M. Barbierato, H. Manev, and P. Giusti Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum Biochem Pharmacol 76 2008 391 403